The 11th Annual BIO Investor Forum Advisory Committee will be annouced Spring 2012. Please see below for last year's committee.
10th Annual BIO Investor Forum Advisory Committee
| John Chambers |
Managing Director & Head of Healthcare Investment Banking |
Roth Capital Partners |
| Annette Grimaldi | Managing Director | BMO Capital Markets |
| James, I. Healy, MD, PhD | General Partner | Sofinnova Ventures, LLC |
| Adam Koppel, MD, PhD | Managing Director | Brookside Capital, LLC |
| Ronald W. Lennox, DPhil | Founder | CHL Medical Partners, LLC |
| Gail Maderis | President & CEO | BayBio |
| Gwen A. Melincoff |
SVP, Business Development, Strategic Investment Group |
Shire Pharmaceuticals, Inc. |
| Jeffrey M. Ostrove, PhD | President & Chief Executive Officer | Ceregene Inc. |
| Andrew J. Schwab | Founder & Managing Partner | 5AM Ventures, LLC |
| Katya Smirnyagina, PhD | Venture Partner | Alta Partners, LLC |
| Samuel Wu, MD, PhD | Managing Director | Medimmune Ventures |
| Asish K. Xavier, PhD | Vice President |
Johnson & Johnson Development Corporation |